Cargando…
Has the development of cancer biomarkers to guide treatment improved health outcomes?
During the last decade, testing the patient’s biomarker status prior to the administration of corresponding co-dependent therapies has been emerging in clinical practice. These biomarker-guided therapies have promoted the promise of more personalized medicine, with the prescription of the right trea...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214594/ https://www.ncbi.nlm.nih.gov/pubmed/33783662 http://dx.doi.org/10.1007/s10198-021-01290-4 |